Yüklüyor......
Suppression of Ongoing T Cell-Mediated Autoimmunity by Peptide-MHC Class II Dimer Vaccination()
Tissue-specific autoimmune diseases such as type 1 diabetes (T1D) are characterized by T cell-driven pathology. Administration of autoantigenic peptides provides a strategy to selectively target the pathogenic T cell response. Indeed, treatment with β cell peptides effectively prevents T1D in NOD mi...
Kaydedildi:
| Yayımlandı: | J Immunol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5444462/ https://ncbi.nlm.nih.gov/pubmed/19752238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.0901616 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|